Profile data is unavailable for this security.
About the company
McKesson Corporation is a healthcare supply chain management solution, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through three segments: United States Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions and Medical-Surgical Solutions. The United States Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare related products and provides pharmaceutical solutions to life sciences companies. European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers. Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers.
- Revenue in USD (TTM)231.05bn
- Net income in USD906.00m
- Incorporated1994
- Employees80.00k
- LocationMckesson Corp6555 State Highway 161IRVING 75039-2402United StatesUSA
- Phone+1 (972) 446-4800
- Fax+1 (302) 636-5454
- Websitehttp://www.mckesson.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Catalent Inc | 2.87bn | 109.80m | 12.00bn | 12.30k | 99.26 | 5.22 | 34.11 | 4.18 | 0.7428 | 0.7428 | 19.29 | 18.04 | 0.4964 | 6.82 | 4.36 | 233,528.50 | 2.38 | 3.69 | 2.72 | 4.22 | 31.51 | 31.81 | 4.79 | 6.47 | 1.55 | 2.05 | 0.5337 | 0.00 | 2.22 | 6.62 | 8.87 | 48.70 | 12.25 | -- |
| Sarepta Therapeutics Inc | 407.50m | -655.92m | 12.78bn | 743.00 | -- | 11.16 | -- | 31.37 | -8.83 | -8.83 | 5.45 | 14.69 | 0.1659 | 0.3644 | 5.18 | 548,446.80 | -26.71 | -34.31 | -29.36 | -38.86 | 85.98 | -- | -160.96 | -191.55 | 7.75 | -49.14 | 0.3754 | -- | 26.51 | 108.11 | -97.58 | -- | 18.51 | -- |
| EXACT Sciences Corporation | 1.06bn | -106.63m | 12.94bn | 4.11k | -- | 5.08 | -- | 12.18 | -0.7663 | -0.7663 | 7.77 | 16.98 | 0.3409 | 4.49 | 10.83 | 258,411.40 | -3.42 | -14.64 | -3.66 | -15.93 | 75.98 | 72.26 | -10.04 | -40.25 | 5.81 | -5.54 | 0.3775 | -- | 92.82 | 244.80 | 52.04 | -- | 70.67 | -- |
| Cardinal Health Inc | 153.59bn | -4.16bn | 14.66bn | 49.50k | -- | 12.19 | -- | 0.0955 | -14.04 | -14.04 | 519.75 | 4.12 | 3.75 | 11.53 | 18.18 | 3,102,748.00 | -10.14 | 2.60 | -24.91 | 6.02 | 4.53 | 5.16 | -2.71 | 0.7268 | 0.5286 | 7.55 | 0.8576 | 59.41 | 6.38 | 9.83 | 300.44 | 3.22 | 5.67 | 9.50 |
| BioNTech SE - ADR | 153.40m | -130.18m | 15.85bn | 1.18k | -- | 36.21 | -- | 103.33 | -0.5754 | -0.5754 | 0.678 | 1.92 | -- | -- | -- | -- | -- | -- | -- | -- | 88.28 | -- | -85.07 | -- | 3.65 | -- | 0.1753 | -- | -14.88 | -- | -272.89 | -- | -- | -- |
| Alnylam Pharmaceuticals, Inc. | 285.93m | -886.42m | 18.37bn | 1.32k | -- | 13.42 | -- | 64.25 | -8.03 | -8.03 | 2.59 | 11.93 | 0.1332 | 0.6982 | 5.23 | 216,124.00 | -41.29 | -35.69 | -46.58 | -39.36 | 87.75 | -- | -310.01 | -600.53 | 4.48 | -- | 0.00 | -- | 193.36 | 34.16 | -16.24 | -- | 32.78 | -- |
| AmerisourceBergen Corp. | 186.16bn | 1.58bn | 19.99bn | 22.00k | 12.95 | 5.57 | 9.88 | 0.1074 | 7.59 | 7.59 | 886.85 | 17.66 | 4.60 | 16.11 | 12.97 | 8,461,793.00 | 3.94 | 2.11 | 16.50 | 8.73 | 2.78 | 2.78 | 0.8552 | 0.4435 | 0.6253 | 15.64 | 0.528 | 43.62 | 6.94 | 8.48 | -21.75 | 23.77 | 3.24 | 11.22 |
| BioMarin Pharmaceutical Inc. | 1.81bn | 114.01m | 23.14bn | 3.00k | 209.66 | 7.14 | 102.99 | 12.82 | 0.6104 | 0.6104 | 9.87 | 17.92 | 0.3943 | 0.6154 | 4.57 | 601,590.10 | 2.49 | -4.79 | 2.91 | -5.56 | 78.86 | 80.38 | 6.31 | -15.01 | 1.72 | -2.09 | 0.2101 | -- | 14.27 | 17.86 | 69.11 | -- | 6.90 | -- |
| Incyte Corporation | 2.23bn | -376.05m | 23.62bn | 1.46k | -- | 12.16 | -- | 10.59 | -1.74 | -1.74 | 10.24 | 8.93 | 0.8097 | 9.24 | 7.49 | 1,531,188.00 | -13.66 | 3.65 | -16.21 | 4.37 | 95.63 | 96.02 | -16.87 | 4.76 | 3.38 | -- | 0.0258 | 0.00 | 14.71 | 33.37 | 308.16 | -- | 22.87 | -- |
| McKesson Corporation | 231.05bn | 906.00m | 23.64bn | 80.00k | 29.06 | 4.64 | 11.54 | 0.1023 | 5.02 | 4.99 | 1,264.30 | 31.43 | 3.82 | 13.10 | 12.10 | 2,888,138.00 | 1.86 | 2.83 | 6.01 | 8.00 | 5.20 | 5.53 | 0.4873 | 0.7993 | 0.598 | 1.67 | 0.524 | 18.06 | 7.81 | 5.23 | 1,809.43 | -12.59 | -1.47 | 10.76 |
| Moderna Inc | 52.57m | -505.59m | 23.68bn | 830.00 | -- | 13.78 | -- | 450.51 | -1.50 | -1.50 | 0.1561 | 4.43 | 0.0271 | -- | 7.56 | 63,340.96 | -26.10 | -- | -28.25 | -- | -- | -- | -961.70 | -- | -- | -- | 0.0232 | -- | -55.42 | -- | -27.91 | -- | -- | -- |
| Iqvia Holdings Inc | 11.16bn | 215.00m | 27.11bn | 67.00k | 130.74 | 4.89 | 18.36 | 2.43 | 1.09 | 1.09 | 56.33 | 29.02 | 0.4832 | -- | 4.38 | 166,537.30 | 1.10 | 1.50 | 1.32 | 1.83 | 33.89 | 33.19 | 2.27 | 2.88 | -- | 1.93 | 0.6757 | 0.00 | 6.49 | 15.22 | -14.73 | -11.73 | 47.75 | -- |
| Seattle Genetics, Inc. | 956.03m | -313.72m | 30.49bn | 1.61k | -- | 17.22 | -- | 31.89 | -1.86 | -1.86 | 5.68 | 10.23 | 0.519 | 0.83 | 5.01 | 595,656.10 | -17.03 | -14.09 | -19.49 | -16.76 | 93.40 | 90.52 | -32.82 | -27.33 | 4.18 | -8.10 | 0.00 | -- | 40.02 | 26.17 | 28.76 | -- | 32.73 | -- |
Data as of Jul 08 2020. Currency figures normalised to Mckesson Corp's reporting currency: US Dollar USD
34.22%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2020 | 13.80m | 8.53% |
| BlackRock Fund Advisorsas of 31 Mar 2020 | 8.13m | 5.03% |
| SSgA Funds Management, Inc.as of 31 Mar 2020 | 7.64m | 4.72% |
| Massachusetts Financial Services Co.as of 31 Mar 2020 | 5.59m | 3.46% |
| Boston Partners Global Investors, Inc.as of 31 Mar 2020 | 4.05m | 2.50% |
| Invesco Advisers, Inc.as of 31 Mar 2020 | 3.73m | 2.31% |
| Pzena Investment Management LLCas of 31 Mar 2020 | 3.45m | 2.13% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2020 | 3.13m | 1.93% |
| Citadel Advisors LLCas of 31 Mar 2020 | 3.09m | 1.91% |
| Geode Capital Management LLCas of 31 Mar 2020 | 2.77m | 1.71% |
More ▼
Data from 31 Mar 2020 - 31 Mar 2020Source: FactSet Research Systems Inc.
